ribavirin has been researched along with Addiction, Opioid in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar, H; Cohen, DE; Felizarta, F; Galen, E; King, M; Kowdley, KV; Lalezari, J; McGovern, B; Polepally, AR; Rustgi, V; Sullivan, JG; Varunok, P | 1 |
| Alavi, M; Balcomb, AC; Bath, N; Day, CA; Dore, GJ; Dunlop, AJ; Grebely, J; Haber, PS; Micallef, M; Phung, N; Treloar, C; Weltman, MD | 1 |
| Arnsten, JH; Gourevitch, MN; Harris, KA; Kaswan, D; Litwin, AH; Nahvi, S; Soloway, IJ; Tenore, PL; Zamor, PJ | 1 |
| Ebner, N; Fischer, G; Jachmann, CA; Matzenauer, C; Thau, K; Wanner, C; Winklbaur, B | 1 |
| Guadagnino, V | 1 |
| Almeida, C; Cifuentes, C; Claro, E; García-Rey, S; Gilabert, I; Macías, J; Merchante, N; Mira, JA; Neukam, K; Pineda, JA; Vázquez, MJ | 1 |
| Acosta, A; Altice, FL; Bruce, RD; Eiserman, J; Gote, C; Lim, JK | 1 |
| Campbell, SA; Tirado, CF; Weinrieb, RM; Zickmund, SL; Zook, CL | 1 |
| Fireman, M; Hauser, P; Matthews, AM; Sobel, M; Zucker, B | 1 |
| Aikaterini, T; Barbara, M; Claudio, I; Daniela, C; Danila, C; Davide, P; Gaetano, B; Giuseppe, A; Luca, I; Luciano, C; Massimo, L; Salvatore, T; Sergio, N; Stefano, C | 1 |
| Bourgeois, JA; Craemer, E; Hancock, MM; Lester, L; Prosser, CC; Ransibrahmanakul, K; Rossaro, L | 1 |
| Heger, B; Krook, AL; Nygaard, E; Stokka, D | 1 |
| Battegay, E; Mettler, J; Zimmerli, L | 1 |
| Backmund, M; Eichenlaub, D; Meyer, K; Von Zielonka, M | 1 |
1 review(s) available for ribavirin and Addiction, Opioid
| Article | Year |
|---|---|
Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patients.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Chronic Disease; Female; Genotype; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Opioid-Related Disorders; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Retention, Psychology; Ribavirin; Young Adult | 2009 |
5 trial(s) available for ribavirin and Addiction, Opioid
| Article | Year |
|---|---|
Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine.
Topics: 2-Naphthylamine; Adolescent; Adult; Aged; Analgesics, Opioid; Anilides; Antiviral Agents; Buprenorphine; Carbamates; Cyclopropanes; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Methadone; Middle Aged; Opioid-Related Disorders; Proline; Retrospective Studies; Ribavirin; Sulfonamides; Uracil; Valine; Young Adult | 2015 |
Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patients.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Chronic Disease; Female; Genotype; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Opioid-Related Disorders; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Retention, Psychology; Ribavirin; Young Adult | 2009 |
Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication.
Topics: Adult; Antiviral Agents; Directly Observed Therapy; Female; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Medication Adherence; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Self Administration; Viral Load | 2012 |
Perceived barriers to hepatitis C therapy for patients receiving opioid agonist treatment.
Topics: Adult; Antiviral Agents; Attitude to Health; Cohort Studies; Comorbidity; Comprehension; Health Services Accessibility; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interview, Psychological; Male; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Education as Topic; Patient Selection; Recombinant Proteins; Ribavirin; Treatment Refusal | 2012 |
Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study.
Topics: Administration, Oral; Adult; Antiviral Agents; Buprenorphine; Comorbidity; Drug Therapy, Combination; Feasibility Studies; Female; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Methadone; Middle Aged; Narcotics; Norway; Opioid-Related Disorders; Patient Compliance; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Social Support; Substance Abuse, Intravenous | 2007 |
10 other study(ies) available for ribavirin and Addiction, Opioid
| Article | Year |
|---|---|
Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study.
Topics: Adult; Aged; Ambulatory Care; Antiviral Agents; Community Health Centers; Delivery of Health Care; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Medication Adherence; Middle Aged; New South Wales; Opiate Substitution Treatment; Opioid-Related Disorders; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Treatment Outcome | 2016 |
Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program.
Topics: Adult; Analgesics, Opioid; Antiviral Agents; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Methadone; Opioid-Related Disorders; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome; United States | 2009 |
Comment to "Treating chronic hepatitis C in recovering opiate addicts: yes, we can".
Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Opioid-Related Disorders; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2010 |
Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment.
Topics: Adult; Antiviral Agents; Cohort Studies; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Prospective Studies; Ribavirin; Treatment Outcome; Viral Load | 2012 |
[Quality assurance in patient addiction treated with drug substitution].
Topics: Antiviral Agents; Buprenorphine; Comorbidity; Drug Information Services; Drug Interactions; Drug Therapy, Combination; Education, Medical, Continuing; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Methadone; Multimedia; Narcotic Antagonists; Opioid-Related Disorders; Polyethylene Glycols; Quality Assurance, Health Care; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load | 2005 |
Relapse to opioid use after treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Topics: Antiviral Agents; Behavior, Addictive; Cocaine-Related Disorders; Comorbidity; Drug Administration Schedule; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferons; Male; Methadone; Middle Aged; Opioid-Related Disorders; Patient Care Planning; Recurrence; Ribavirin; Risk Assessment; Substance Abuse, Intravenous; Treatment Outcome | 2006 |
Immune response in addicts with chronic hepatitis C treated with interferon and ribavirin.
Topics: Adult; Antiviral Agents; Case-Control Studies; Chi-Square Distribution; Disease Progression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Methadone; Opioid-Related Disorders; Recombinant Proteins; Ribavirin; Statistics, Nonparametric; Viral Load | 2007 |
Liver transplant and hepatitis C in methadone maintenance therapy: a case report.
Topics: Adult; Analgesics, Opioid; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferons; Liver; Liver Transplantation; Male; Methadone; Opioid-Related Disorders; Ribavirin; Secondary Prevention; Viral Load | 2007 |
[Chronic fatigue. IV--Assessment of a 40-year-old patient].
Topics: Adult; Anemia, Iron-Deficiency; Antiviral Agents; Diagnosis, Differential; Drug Therapy, Combination; Fatigue Syndrome, Chronic; Hashimoto Disease; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Male; Methadone; Narcotics; Opioid-Related Disorders; Ribavirin; Thyroid Function Tests | 2007 |
Treatment of hepatitis C infection in injection drug users.
Topics: Adult; Alanine Transaminase; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Opioid-Related Disorders; Patient Compliance; Polymerase Chain Reaction; Prospective Studies; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Sex Characteristics; Substance Abuse, Intravenous; Treatment Outcome | 2001 |